Swethajit Biswas

机构：Horphag Research (Switzerland)

发表论文 44 篇 · 总被引 1388 次 · h-index 15

代表论文

• Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial (2024 · The Lancet · 被引 279)
• Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial (2023 · Nature Medicine · 被引 200)
• Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study (2022 · BMC Cardiovascular Disorders · 被引 41)
• SPEARHEAD-1: A phase 2 trial of afamitresgene autoleucel (Formerly ADP-A2M4) in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma. (2021 · Journal of Clinical Oncology · 被引 37)
• Identification of response stratification factors from pooled efficacy analyses of afamitresgene autoleucel (“Afami-cel” [Formerly ADP-A2M4]) in metastatic synovial sarcoma and myxoid/round cell liposarcoma phase 1 and phase 2 trials. (2022 · Journal of Clinical Oncology · 被引 14)
• SPEARHEAD-1: A phase II trial of ADP-A2M4 SPEAR T cells in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma. (2020 · Journal of Clinical Oncology · 被引 10)